The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cellsGabriele Greve, Michael Lübbert|BMC Cancer|2015Cited by 71
Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia CellsEva‐Maria Herrlinger, Manfred Jung, Desiree Melanie Redhaber et al.|ChemBioChem|2020Cited by 22